Similarly, for midlife-to-late-life activity patterns, cognitive impairment risk did not differ significantly between APOE ε4 carriers who maintained activity levels and non-carriers who maintained activity levels (P-value > 0.05). The gene discussed is APOE; the disease is Cognitive impairment.